Elanco Animal Health Inc
ELAN22.305USD
+0.215+0.97%
收盘 12/19, 16:00（美东）报价延迟15分钟
11.08B总市值
308.38市盈率 TTM
关于 Elanco Animal Health Inc 公司
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Inc简介
公司代码ELAN
公司名称Elanco Animal Health Inc
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
员工数量9000
证券类型Ordinary Share
年结日Sep 20
公司地址450 Elanco Circle
城市INDIANAPOLIS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编46221
电话18773526261
网址https://www.elanco.com/
公司代码ELAN
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
Elanco Animal Health Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
160.34K
+6.87%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
+10.39%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
+12.74%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
+12.99%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
84.81K
+13.84%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1.82%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+100.82%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
160.34K
+6.87%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
+10.39%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
+12.74%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
+12.99%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Pet Health
643.00M
51.81%
Farm Animal
583.00M
46.98%
Contract Manufacturing
15.00M
1.21%
地区USD
名称
营收
占比
International
648.00M
52.22%
United States
593.00M
47.78%
业务
地区
业务USD
名称
营收
占比
Pet Health
643.00M
51.81%
Farm Animal
583.00M
46.98%
Contract Manufacturing
15.00M
1.21%
股东统计
更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Dodge & Cox
16.66%
Fidelity Management & Research Company LLC
10.21%
PRIMECAP Management Company
10.05%
The Vanguard Group, Inc.
9.75%
BlackRock Institutional Trust Company, N.A.
8.13%
其他
45.19%
持股股东
持股股东
占比
Dodge & Cox
16.66%
Fidelity Management & Research Company LLC
10.21%
PRIMECAP Management Company
10.05%
The Vanguard Group, Inc.
9.75%
BlackRock Institutional Trust Company, N.A.
8.13%
其他
45.19%
股东类型
持股股东
占比
Investment Advisor
70.39%
Investment Advisor/Hedge Fund
36.66%
Hedge Fund
5.79%
Research Firm
1.90%
Individual Investor
1.13%
Pension Fund
1.08%
Bank and Trust
0.65%
Sovereign Wealth Fund
0.18%
Family Office
0.11%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
852
577.24M
120.43%
+30.91K
2025Q3
891
577.57M
121.95%
+32.95M
2025Q2
878
543.55M
113.98%
+36.20M
2025Q1
945
503.90M
116.31%
-73.53M
2024Q4
964
498.16M
117.36%
+7.74M
2024Q3
970
490.73M
118.81%
+19.54K
2024Q2
1004
491.01M
118.24%
+1.27M
2024Q1
1021
489.85M
119.72%
-100.34M
2023Q4
1018
489.74M
120.73%
-3.72M
2023Q3
1027
490.57M
119.00%
+3.49M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
82.90M
16.69%
-25.35K
-0.03%
Jun 30, 2025
Fidelity Management & Research Company LLC
48.24M
9.71%
+9.93M
+25.93%
Jun 30, 2025
PRIMECAP Management Company
51.77M
10.42%
+1.54M
+3.07%
Jun 30, 2025
The Vanguard Group, Inc.
47.65M
9.59%
-496.16K
-1.03%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
19.58M
3.94%
-484.75K
-2.42%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
19.55M
3.94%
+3.57M
+22.35%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
22.75M
4.58%
+2.28M
+11.15%
Jun 30, 2025
UBS Financial Services, Inc.
10.31M
2.08%
+5.99M
+138.56%
Jun 30, 2025
State Street Investment Management (US)
9.13M
1.84%
-125.36K
-1.35%
Jun 30, 2025
Fidelity Institutional Asset Management
16.64M
3.35%
+1.09M
+7.01%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares U.S. Pharmaceuticals ETF
4.06%
Adaptiv Select ETF
3.38%
State Street SPDR S&P Pharmaceuticals ETF
3.15%
Brandes US Small-Mid Cap Value ETF
3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.84%
VanEck Agribusiness ETF
2.3%
First Trust Health Care Alphadex Fund
1.92%
Federated Hermes MDT Large Cap Value ETF
1.9%
First Trust NASDAQ Pharmaceuticals ETF
1.33%
Invesco S&P MidCap 400 Pure Value ETF
1.22%
查看更多
iShares U.S. Pharmaceuticals ETF
占比4.06%
Adaptiv Select ETF
占比3.38%
State Street SPDR S&P Pharmaceuticals ETF
占比3.15%
Brandes US Small-Mid Cap Value ETF
占比3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.84%
VanEck Agribusiness ETF
占比2.3%
First Trust Health Care Alphadex Fund
占比1.92%
Federated Hermes MDT Large Cap Value ETF
占比1.9%
First Trust NASDAQ Pharmaceuticals ETF
占比1.33%
Invesco S&P MidCap 400 Pure Value ETF
占比1.22%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Elanco Animal Health Inc的前五大股东是谁？
Elanco Animal Health Inc 的前五大股东如下：
Dodge & Cox持有股份：82.90M，占总股份比例：16.69%。
Fidelity Management & Research Company LLC持有股份：48.24M，占总股份比例：9.71%。
PRIMECAP Management Company持有股份：51.77M，占总股份比例：10.42%。
The Vanguard Group, Inc.持有股份：47.65M，占总股份比例：9.59%。
BlackRock Institutional Trust Company, N.A.持有股份：19.58M，占总股份比例：3.94%。
Dodge & Cox持有股份：82.90M，占总股份比例：16.69%。
Fidelity Management & Research Company LLC持有股份：48.24M，占总股份比例：9.71%。
PRIMECAP Management Company持有股份：51.77M，占总股份比例：10.42%。
The Vanguard Group, Inc.持有股份：47.65M，占总股份比例：9.59%。
BlackRock Institutional Trust Company, N.A.持有股份：19.58M，占总股份比例：3.94%。
Elanco Animal Health Inc的前三大股东类型是什么？
Elanco Animal Health Inc 的前三大股东类型分别是：
Dodge & Cox
Fidelity Management & Research Company LLC
PRIMECAP Management Company
Dodge & Cox
Fidelity Management & Research Company LLC
PRIMECAP Management Company
有多少机构持有Elanco Animal Health Inc(ELAN)的股份？
截至2025Q4，共有852家机构持有Elanco Animal Health Inc的股份，合计持有的股份价值约为577.24M，占公司总股份的120.43%。与2025Q3相比，机构持股有所增加，增幅为-1.52%。
哪个业务部门对Elanco Animal Health Inc的收入贡献最大？
在FY2025Q2，Pet Health业务部门对Elanco Animal Health Inc的收入贡献最大，创收643.00M，占总收入的51.81%。
